Ardelyx Inc.

3.95+0.2900+7.92%Vol 8.22M1Y Perf 207.56%
Sep 22nd, 2023 16:00 DELAYED
BID3.95 ASK4.00
Open3.84 Previous Close3.66
Pre-Market- After-Market3.95
 - -  - -%
Target Price
5.75 
Analyst Rating
Strong Buy 1.00
Potential %
45.57 
Finscreener Ranking
★★★     48.51
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
     38.37
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★     45.63
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
70.88 
Earnings Rating
Strong Buy
Market Cap860.56M 
Earnings Date
2nd Nov 2023
Alpha0.02 Standard Deviation0.24
Beta1.16 

Today's Price Range

3.624.00

52W Range

1.095.13

5 Year PE Ratio Range

-2.90-5.20

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-13.19%
1 Month
7.63%
3 Months
9.72%
6 Months
-2.71%
1 Year
207.56%
3 Years
-28.83%
5 Years
-4.82%
10 Years
-

TickerPriceChg.Chg.%
ARDX3.950.29007.92
AAPL174.790.86000.49
GOOG131.25-0.1100-0.08
MSFT317.01-2.5200-0.79
XOM114.940.18000.16
WFC41.23-1.0900-2.58
JNJ160.50-1.1600-0.72
FB196.640.99000.51
GE111.25-1.7400-1.54
JPM145.73-1.4100-0.96
Financial StrengthValueIndustryS&P 500US Markets
1.80
2.30
0.09
0.56
-26.00
Leverage Ratio 2.20
ProfitabilityValueIndustryS&P 500US Markets
89.40
-1 219.80
-1 218.00
-2 042.30
-
RevenueValueIndustryS&P 500US Markets
7.98M
0.04
121.17
-
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.12-0.0833.33
Q01 2023-0.11-0.13-18.18
Q04 20220.010.06500.00
Q03 2022-0.17-0.1417.65
Q02 2022-0.19-0.190.00
Q01 2022-0.20-0.21-5.00
Q04 2021-0.25-0.31-24.00
Q03 2021-0.34-0.42-23.53
Earnings Per EndEstimateRevision %Trend
9/2023 QR-0.118.33Positive
12/2023 QR-0.050.00-
12/2023 FY-0.3811.63Positive
12/2024 FY-0.17-1 600.00Negative
Next Report Date2nd Nov 2023
Estimated EPS Next Report-0.11
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume8.22M
Shares Outstanding217.86K
Shares Float205.88M
Trades Count27.99K
Dollar Volume31.60M
Avg. Volume6.40M
Avg. Weekly Volume7.81M
Avg. Monthly Volume6.44M
Avg. Quarterly Volume4.96M

Ardelyx Inc. (NASDAQ: ARDX) stock closed at 3.95 per share at the end of the most recent trading day (a 7.92% change compared to the prior day closing price) with a volume of 8.22M shares and market capitalization of 860.55M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 88 people. Ardelyx Inc. CEO is Michael G. Raab.

The one-year performance of Ardelyx Inc. stock is 207.56%, while year-to-date (YTD) performance is 38.6%. ARDX stock has a five-year performance of -4.82%. Its 52-week range is between 1.09 and 5.125, which gives ARDX stock a 52-week price range ratio of 70.88%

Ardelyx Inc. currently has a PE ratio of -3.40, a price-to-book (PB) ratio of 8.05, a price-to-sale (PS) ratio of 63.90, a price to cashflow ratio of 58.30, a PEG ratio of -, a ROA of -78.88%, a ROC of -88.91% and a ROE of -168.04%. The company’s profit margin is -%, its EBITDA margin is -1 218.00%, and its revenue ttm is $7.98 Million , which makes it $0.04 revenue per share.

Of the last four earnings reports from Ardelyx Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.11 for the next earnings report. Ardelyx Inc.’s next earnings report date is 02nd Nov 2023.

The consensus rating of Wall Street analysts for Ardelyx Inc. is Strong Buy (1), with a target price of $5.75, which is +45.57% compared to the current price. The earnings rating for Ardelyx Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Ardelyx Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Ardelyx Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 9.84, ATR14 : 0.29, CCI20 : -114.85, Chaikin Money Flow : 0.00, MACD : 0.01, Money Flow Index : 35.06, ROC : -16.49, RSI : 45.23, STOCH (14,3) : 24.44, STOCH RSI : 0.33, UO : 32.49, Williams %R : -75.56), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Ardelyx Inc. in the last 12-months were: Blanks Robert (Option Excercise at a value of $113 999), Blanks Robert (Option Exercise at a value of $113 999), Blanks Robert (Sold 75 741 shares of value $272 674 ), David M. Mott (Buy at a value of $1 000 641), David P. Rosenbaum (Sold 1 948 shares of value $3 797 ), Elizabeth Grammer (Sold 1 242 shares of value $2 421 ), Grammer Elizabeth (Sold 5 298 shares of value $17 444 ), Justin A. Renz (Sold 7 816 shares of value $23 735 ), Laura Williams (Sold 1 241 shares of value $2 419 ), Michael G. Raab (Sold 6 219 shares of value $12 120 ), Raab Michael (Sold 36 225 shares of value $122 338 ), Robert Blanks (Sold 101 464 shares of value $152 853 ), Robert Ora Felsch (Sold 5 308 shares of value $17 180 ), Rodriguez Susan (Sold 15 030 shares of value $50 755 ), Rosenbaum David (Sold 17 957 shares of value $67 782 ), Susan Rodriguez (Sold 3 456 shares of value $6 736 ), Williams Laura (Sold 27 591 shares of value $92 948 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (100.00 %)
6 (85.71 %)
6 (85.71 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
1 (14.29 %)
1 (14.29 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.29
Strong Buy
1.29

Ardelyx Inc.

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

CEO: Michael G. Raab

Telephone: +1 510 745-1700

Address: 34175 Ardenwood Boulrvard, Fremont 94555, CA, US

Number of employees: 88

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

47%53%

Bearish Bullish

59%41%

Bearish Bullish

61%39%

 

News

Stocktwits